RA Capital Management, L.P. 13D and 13G filings for Acrivon Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-11 4:16 pm Purchase |
2024-04-11 | 13D | Acrivon Therapeutics, Inc. Common Stock ACRV |
RA Capital Management, L.P. | 8,359,102 27.100% |
3,541,743 (+73.52%) |
Filing |
| 2023-03-30 5:07 pm Purchase |
2023-03-28 | 13D | Acrivon Therapeutics, Inc. Common Stock ACRV |
RA Capital Management, L.P. | 4,817,359 22.000% |
3,917 (+0.08%) |
Filing |
| 2022-11-28 4:31 pm Purchase |
2022-11-17 | 13D | Acrivon Therapeutics, Inc. Common Stock ACRV |
RA Capital Management, L.P. | 4,813,442 23.070% |
4,813,442 (New Position) |
Filing |